Home LiteratureArticle Details
PMID: 11956100 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Cell division is required for de novo methylation of CpG islands in bladder cancer cells.

Cancer research ·Vol. 62 ·No. 8 ·2002-04-15 ·Pages 2378-84

Velicescu M, Weisenberger DJ, Gonzales FA, Tsai YC, Nguyen CT, Jones PA

Abstract

Cell division is essential for tumor development and progression. Methylation-mediated silencing caused by aberrant de novo methylation of CpG islands located in the promoter regions of growth regulatory genes occurs frequently in human cancers. We investigated the relationship between cell division and de novo methylation to determine whether de novo methylation can occur in the absence of cell division in cancer cells. We treated T24 bladder carcinoma cells with 5-Aza-2'-deoxycytidine to induce a transient demethylation and then compared the timing and kinetics of remethylation of the p16 gene locus under conditions of either G(0)-G(1) growth arrest induced by serum starvation and confluence or continuous cell proliferation in complete medium. Variable levels of remethylation were detected in CpG poor regions of DNA, as well as repetitive DNA elements in the absence of cell division, yet no remethylation occurred at CpG islands under these conditions. This correlated with continuous expression of p16 protein in these cells. DNA methyltransferase (DNMT)1 and DNMT3b3 proteins were undetectable in 5-Aza-2'-deoxycytidine-treated and untreated nondividing cells, and their mRNA transcripts were down-regulated in these cells. Although DNMT3a mRNA levels were also reduced, they recovered to original levels in nondividing cells after drug treatment. Our results suggest that cell division is required for de novo methylation of CpG islands and that DNMT3a may play a role in methylating CpG poor regions or repetitive DNA elements outside of the S phase of the cell cycle.

MeSH Terms
Antimetabolites, Antineoplastic/pharmacology Azacitidine/analogs & derivatives,pharmacology Carcinoma, Transitional Cell/genetics,metabolism,pathology Cell Division/physiology CpG Islands/drug effects,physiology Cyclin-Dependent Kinase Inhibitor p16/biosynthesis,genetics DNA (Cytosine-5-)-Methyltransferase 1 DNA (Cytosine-5-)-Methyltransferases/biosynthesis,genetics DNA Methylation/drug effects DNA Methyltransferase 3A Decitabine Down-Regulation Gene Expression Regulation, Enzymologic/drug effects Gene Expression Regulation, Neoplastic/drug effects Genes, p16/physiology Humans Kinetics RNA, Messenger/biosynthesis,genetics Tumor Cells, Cultured Urinary Bladder Neoplasms/genetics,metabolism,pathology
Chemicals
Antimetabolites, Antineoplastic Cyclin-Dependent Kinase Inhibitor p16 DNMT3A protein, human RNA, Messenger Decitabine DNA (Cytosine-5-)-Methyltransferase 1 DNA (Cytosine-5-)-Methyltransferases DNA Methyltransferase 3A Azacitidine
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Velicescu Mihaela
Urologic Cancer Research Laboratory, Department of Biochemistry and Molecular Biology, University of Southern California/Norris Comprehensive Cancer Center, 1441 Eastlake Avenue, Los Angeles, CA 90089-9181, USA.
Weisenberger Daniel J
Gonzales Felicidad A
Tsai Yvonne C
Nguyen Carvell T
Jones Peter A
Article Info
Journal
Cancer research
Abbr.
Cancer Res
ISSN
0008-5472
Published
2002-04-15
Pages
2378-84
Language
English
Region
United States
NLM ID
2984705R
Subset
IM
Grants
NCI NIH HHS · 1R01 CA 82422-01 · United States
NCI NIH HHS · 1R01 CA 83867-01 · United States
NCI NIH HHS · T32 CA 09659 · United States
NIDCR NIH HHS · T32 DE 07211-11 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]